DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2221920/earnings-data-deluge?cid=CS-ZC-FT-economic_highlights-2221920 Feb 06, 2024 - Earnings Data Deluge. 0

https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001 Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs. 0

https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190 Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements. 0

https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/?source=iedfolrf0000001 Feb 10, 2024 - Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years. 0

https://www.zacks.com/stock/news/2225655/incyte-s-incy-q4-earnings-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2225655 Feb 13, 2024 - Incyte's (INCY) fourth-quarter 2023 earnings and revenues miss estimates. Quarterly revenues cross the $1 billion mark for the first time on the continued growth of Jakafi and the strong launch of Opzelura. 0

https://www.fool.com/investing/2024/02/19/3-magnificent-growth-stocks-to-buy-right-now/?source=iedfolrf0000001 Feb 19, 2024 - These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. 0

https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353 Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS). 0

https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/?source=iedfolrf0000001 Mar 02, 2024 - Eli Lilly stock is having a moment, but the company could easily continue soaring. 0

https://www.zacks.com/stock/news/2238098/s-p-500-soars-to-new-highs-5-best-stocks-ytd?cid=CS-ZC-FT-etf_news_and_commentary-2238098 Mar 08, 2024 - The S&P 500 soared to new all-time highs on reassuring comments regarding potential interest rate declines. SPDR S&P 500 ETF Trust (SPY), the proxy version of the S&P 500 Index, has risen 8.3% so far this year. 0

https://www.zacks.com/stock/news/2238077/novo-nordisk-nvo-up-on-upbeat-data-from-new-obesity-pill-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238077 Mar 08, 2024 - Novo Nordisk (NVO) stock rises as it presents encouraging efficacy data on a new investigational oral obesity pill, amycretin, at its Capital Markets Day. 0